Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07163988 · ClinicalTrials.gov registry record
Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I
A clinical trial, sponsored by Rohan Dharmakumar.
- Completed
- Registry status
- 312
- Enrollment target
NCT07163988 is a clinical trial that has completed, run by Rohan Dharmakumar. The registered enrollment target is 312 participants.
The verdict
NCT07163988 has completed, sponsored by Rohan Dharmakumar.
- COMPLETED
- Registry status
- 312 participants
- Enrollment target
Study Summary
TROP-MI-STAGE is a multicenter retrospective diagnostic study designed to evaluate the role of high-sensitivity cardiac troponin I (hs-cTnI) in the diagnosis and clinical stage classification of acute myocardial infarction as defined by the stages of myocardial injury in CCS-AMI classification. The study retrospectively analyzes biomarker data from patients diagnosed with AMI across multiple institutions, focusing on whether hs-cTnI levels-measured at specific time points-can reliably identify and stratify patients into AMI clinical stages (Stage 1 to Stage 4). It aims to correlate hs-cTnI kinetics and peak levels with clinical stage, presentation patterns, and outcomes. This trial seeks to offer a biomarker-based alternative to imaging-heavy staging, potentially streamlining early diagnosis and therapeutic triage for AMI patients in varied clinical settings.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2023-01-10 |
| Est. Completion | 2025-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07163988
The ClinicalTrials.gov registry entry for NCT07163988 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rohan Dharmakumar, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07163988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07163988 about?
NCT07163988 is a clinical study titled "Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I". TROP-MI-STAGE is a multicenter retrospective diagnostic study designed to evaluate the role of high-sensitivity cardiac troponin I (hs-cTnI) in the diagnosis and clinical stage classification of acute myocardial infarction as defined by the stages of myocardial injury in CCS-AMI classification. The...
What is the current status of trial NCT07163988?
This trial is currently completed. The enrollment target is 312 participants. The study started on 2023-01-10. Estimated completion is 2025-09-30.
Who is sponsoring clinical trial NCT07163988?
This trial is sponsored by Rohan Dharmakumar, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.